Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-06

Clinical Trial Update: A Study to Investigate Mechanisms of Resistance to Breast Cancer Therapies [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial sponsored by Hoffmann-La Roche is recruiting to investigate mechanisms of resistance to breast cancer therapies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 4 | Status: RECRUITING